PL2392329T3 - Kompozycje do stosowania w leczeniu zespołów mielodysplastycznych - Google Patents
Kompozycje do stosowania w leczeniu zespołów mielodysplastycznychInfo
- Publication number
- PL2392329T3 PL2392329T3 PL11168376T PL11168376T PL2392329T3 PL 2392329 T3 PL2392329 T3 PL 2392329T3 PL 11168376 T PL11168376 T PL 11168376T PL 11168376 T PL11168376 T PL 11168376T PL 2392329 T3 PL2392329 T3 PL 2392329T3
- Authority
- PL
- Poland
- Prior art keywords
- compositions
- myelodysplastic syndrome
- treating myelodysplastic
- treating
- syndrome
- Prior art date
Links
- 201000003793 Myelodysplastic syndrome Diseases 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oncology (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US35237410P | 2010-06-07 | 2010-06-07 | |
| US10875611A | 2011-05-16 | 2011-05-16 | |
| US13/108,756 US20110301199A1 (en) | 2010-06-07 | 2011-05-16 | Compositions and methods for treating myelodysplastic syndrome |
| EP11168376A EP2392329B1 (en) | 2010-06-07 | 2011-06-01 | Compositions for use in treating myelodysplastic syndrome |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2392329T3 true PL2392329T3 (pl) | 2013-03-29 |
Family
ID=44644899
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL11168376T PL2392329T3 (pl) | 2010-06-07 | 2011-06-01 | Kompozycje do stosowania w leczeniu zespołów mielodysplastycznych |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20110301199A1 (pl) |
| EP (1) | EP2392329B1 (pl) |
| JP (1) | JP2012025734A (pl) |
| CN (1) | CN102389564A (pl) |
| AU (1) | AU2011202637A1 (pl) |
| CA (1) | CA2742032A1 (pl) |
| DK (1) | DK2392329T3 (pl) |
| ES (1) | ES2396468T3 (pl) |
| PL (1) | PL2392329T3 (pl) |
| SM (1) | SMT201200064B (pl) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8759303B2 (en) * | 2010-06-07 | 2014-06-24 | Telik, Inc. | Compositions and methods for treating myelodysplastic syndrome |
| CN105688185B (zh) * | 2016-03-13 | 2019-03-19 | 浙江药苑生物科技有限公司 | 一种用于治疗骨髓增生、骨癌的药物组合物及其用途 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5599903A (en) | 1992-04-03 | 1997-02-04 | Terrapin Technologies, Inc. | Glutathione analogs and paralog panels comprising glutathione mimics |
| US7029695B2 (en) | 2001-07-10 | 2006-04-18 | Telik, Inc. | Therapeutic compositions containing glutathione analogs |
| US7189740B2 (en) * | 2002-10-15 | 2007-03-13 | Celgene Corporation | Methods of using 3-(4-amino-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for the treatment and management of myelodysplastic syndromes |
-
2011
- 2011-05-16 US US13/108,756 patent/US20110301199A1/en not_active Abandoned
- 2011-06-01 PL PL11168376T patent/PL2392329T3/pl unknown
- 2011-06-01 EP EP11168376A patent/EP2392329B1/en not_active Not-in-force
- 2011-06-01 ES ES11168376T patent/ES2396468T3/es active Active
- 2011-06-01 DK DK11168376.9T patent/DK2392329T3/da active
- 2011-06-02 JP JP2011124324A patent/JP2012025734A/ja not_active Withdrawn
- 2011-06-03 CA CA2742032A patent/CA2742032A1/en not_active Abandoned
- 2011-06-03 AU AU2011202637A patent/AU2011202637A1/en not_active Abandoned
- 2011-06-07 CN CN2011101511710A patent/CN102389564A/zh active Pending
-
2012
- 2012-12-27 SM SM201200064T patent/SMT201200064B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2742032A1 (en) | 2011-12-07 |
| DK2392329T3 (da) | 2013-01-02 |
| US20110301199A1 (en) | 2011-12-08 |
| CN102389564A (zh) | 2012-03-28 |
| AU2011202637A1 (en) | 2011-12-22 |
| ES2396468T3 (es) | 2013-02-21 |
| SMT201200064B (it) | 2013-03-08 |
| EP2392329B1 (en) | 2012-10-03 |
| JP2012025734A (ja) | 2012-02-09 |
| EP2392329A1 (en) | 2011-12-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2646468A4 (en) | ANTI-NGF COMPOSITIONS AND THEIR USE | |
| EP2678320A4 (en) | FLUMAZENIL COMPLEXES, COMPOSITIONS THEREOF AND USES THEREOF | |
| IL225924A (en) | Dlbcl treatment | |
| EP2644185A4 (en) | THICK CLEANING COMPOSITION | |
| GB201002983D0 (en) | Nutritinal composition | |
| HK1190936A1 (zh) | 治療代謝綜合徵的方法和配方 | |
| IL232090A (en) | Preparations for use in the treatment of nephropathy | |
| EP2536293A4 (en) | METHODS AND COMPOSITIONS FOR USE IN AQUACULTURE | |
| ZA201208409B (en) | Hard surface treatment composition | |
| EP2575825A4 (en) | COMPOSITIONS AND METHODS FOR TREATING DEPRESSION | |
| ZA201303661B (en) | Cleansing composition | |
| EP2612652A4 (en) | DETERGENT COMPOSITION | |
| EP2785176A4 (en) | ANTIMICROBIAL COMPOSITIONS AND RELATED METHODS | |
| PL2683238T3 (pl) | Kompozycje zawierające kopolimery | |
| HK1188114A1 (en) | Composition for use in treating infertility | |
| PL2534302T3 (pl) | Kompozycja do obróbki powierzchni | |
| EP2668044A4 (en) | COMPOSITIONS AND THEIR USE | |
| ZA201300304B (en) | Multiple unit table composition | |
| IL225483A0 (en) | The compositions and methods for the treatment of neoplasia | |
| IL218726A (en) | Pharmaceuticals for the treatment of Down syndrome | |
| ZA201305497B (en) | Methods and compositions for preventing and treating osteoarthritis | |
| PL2392329T3 (pl) | Kompozycje do stosowania w leczeniu zespołów mielodysplastycznych | |
| GB201118532D0 (en) | Absorbent composition | |
| LT2863931T (lt) | Kompozicijos, skirtos panaudoti žaizdų gydymui | |
| PT2558079T (pt) | Composição de xarope seco de ciprofloxacina |